Befejeződött1/2. fázis
A phase I study evaluating safety and efficacy of Hepatic Intra- Arterial administration of ipilimumab in combination with Intra- venous nivolumab for advanced Hepatocellular carcinoma (HIPANIV)
Key facts
- Where
- Villejuif, FranciaországSee the 2 sites
- Phase
- 1/2. fázis
Where in Franciaország
- Gustave RoussyVillejuif, FranciaországNo longer taking part
- Service Hospitalier Frédéric Joliot - Commissariat à Energie AtomiqueVillejuif, FranciaországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institut Gustave Roussy
- Trial code
- EU 2023-506156-25-00
- Record updated
- 2024. november 8.